IntrinsicIntrinsic

Other Events ·

IGC Pharma, Inc. furnished an updated investor presentation dated July 2026 as part of its Regulation FD disclosure

IGCIGC Pharma, Inc.

IGC Pharma, Inc. furnished an updated investor presentation dated July 2026 as part of its Regulation FD disclosure. The company is a biopharmaceutical company focused on developing and commercializing product candidates like IGC-AD1.

More from IGC Pharma, Inc.

Explore IGC